Advertisement

Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies

Jean-Pierre J. Issa, Guillermo Garcia-Manero, Francis J. Giles, Rajan Mannari, Deborah Thomas, Stefan Faderl, Emel Bayar, John Lyons, Craig S. Rosenfeld, Jorge Cortes and Hagop M. Kantarjian

Article Information

Citation 
vol. 103 no. 5 1635-1640
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted March 3, 2003
  • Accepted October 29, 2003
  • Published online February 18, 2004.


Contributors 
  • Jean-Pierre J. Issa
  • Guillermo Garcia-Manero
  • Francis J. Giles
  • Rajan Mannari
  • Deborah Thomas
  • Stefan Faderl
  • Emel Bayar
  • John Lyons
  • Craig S. Rosenfeld
  • Jorge Cortes
  • Hagop M. Kantarjian

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output